AUDA is primarily used in research settings for its ability to inhibit soluble epoxide hydrolase (sEH), an enzyme involved in the metabolism of bioactive lipids. By inhibiting sEH, AUDA helps increase the levels of epoxyeicosatrienoic acids (EETs), which have anti-inflammatory, vasodilatory, and analgesic effects. This makes AUDA a valuable tool in studying cardiovascular diseases, inflammation, and pain pathways. It has shown potential in preclinical models for reducing hypertension, protecting against ischemic injury, and alleviating neuropathic pain. Due to its biological activity, AUDA is widely used to explore therapeutic strategies for metabolic and inflammatory conditions.